MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition | |
Dai, Mei1; Miao, Ze-Hong1; Ren, Xuan1; Tong, Lin-Jiang1; Yang, Na1; Li, Ting1; Lin, Li-Ping1; Shen, Yue-Mao2; Ding, Jian1![]() | |
刊名 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
![]() |
2010-09 | |
卷号 | 14期号:9页码:2281-2291 |
关键词 | MFTZ-1 HIF-1 alpha VEGF angiogenesis topoisomerase II inhibitor |
ISSN号 | 1582-4934 |
DOI | 10.1111/j.1582-4934.2009.00822.x |
文献子类 | Article |
英文摘要 | The macrolide compound MFTZ-1 has been identified as a novel topoisomerase II (Top2) inhibitor with potent in vitro and in vivo anti-tumour activities. In this study, we further examined the effects of MFTZ-1 on hypoxia-inducible factor-1 alpha (HIF-1 alpha) accumulation, vascular endothelial growth factor (VEGF) secretion and angiogenesis. MFTZ-1 reduced HIF-1 alpha accumulation driven by hypoxia or growth factors in human cancer cells. Mechanistic studies revealed that MFTZ-1 did not affect the degradation of HIF-1 alpha protein or the level of HIF-1 alpha mRNA. By contrast, MFTZ-1 apparently inhibited constitutive and inducible activation of both phosphatidylinositol-3-kinase (PI3K)-Akt and p42/p44 mitogen-activated protein kinase (MAPK) pathways. Further studies revealed that MFTZ-1 abrogated the HIF-1 alpha-driven increase in VEGF mRNA and protein secretion. MFTZ-1 also lowered the basal level of VEGF secretion. The results reveal an important feature that MFTZ-1 can reduce constitutive, HIF-1 alpha-independent VEGF secretion and concurrently antagonize inducible, HIF-1 alpha-dependent VEGF secretion. Moreover, MFTZ-1 disrupted tube formation of human umbilical vein endothelial cells (HUVECs) stimulated by hypoxia with low-concentration serum or by serum at normoxia, and inhibited HUVECs migration at normoxia. MFTZ-1 also prevented microvessel outgrowth from rat aortic ring. These data reflect the potent anti-angiogenesis of MFTZ-1 under different conditions. Furthermore, using specific small interfering RNA targeting Top2 alpha or Top2-defective HL60/MX2 cells, we showed that MFTZ-1 affected HIF-1 alpha accumulation and HUVECs tube formation irrelevant to its Top2 inhibition. Taken together, our data collectively reveal that MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion possibly via PI3K-Akt and MAPK pathways, eliciting anti-angiogenesis independently of its Top2 inhibition. |
资助项目 | National Natural Science Foundation of China (NSFC)[30721005] |
WOS关键词 | GROWTH-FACTOR EXPRESSION ; ENDOTHELIAL-CELLS ; CANCER-CELLS ; FACTOR (HIF)-1-ALPHA ; SIGNALING PATHWAY ; AUTOCRINE LOOP ; HYPOXIA ; ANGIOGENESIS ; FACTOR-1-ALPHA ; PROTEIN |
WOS研究方向 | Cell Biology ; Research & Experimental Medicine |
语种 | 英语 |
出版者 | WILEY |
WOS记录号 | WOS:000282874000014 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/278787] ![]() |
专题 | 药理学第一研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Miao, Ze-Hong |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China; 2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resouces W China, Kunming, Peoples R China |
推荐引用方式 GB/T 7714 | Dai, Mei,Miao, Ze-Hong,Ren, Xuan,et al. MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2010,14(9):2281-2291. |
APA | Dai, Mei.,Miao, Ze-Hong.,Ren, Xuan.,Tong, Lin-Jiang.,Yang, Na.,...&Ding, Jian.(2010).MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,14(9),2281-2291. |
MLA | Dai, Mei,et al."MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 14.9(2010):2281-2291. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论